Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-04

Clinical Trial Update: A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery. [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluated Alli (orlistat) for preoperative weight loss in patients preparing for bariatric surgery. The study targeted obesity and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLI (orlistat)

Snippet

Sponsor: Albany College of Pharmacy and Health Sciences | Conditions: Obesity | Phase 4 | Status: COMPLETED | Results posted: 2014-04-04